After identifying the biomarkers IL-1β, NF-κB, Akt, and GATA3 as drug targets for AD, a DNN-based DTI model was trained on DTI data from DTI databases to predict molecular drugs for these biomarkers of AD, as described in Section 4.1. Here, IL1B is linked to Alzheimer disease.